Assessing the Magnitude of Immunogenic Cell Death Following Chemotherapy and Irradiation Reveals a New Strategy to Treat Pancreatic Cancer-Reference-Cited by-同舟云学术

Assessing the Magnitude of Immunogenic Cell Death Following Chemotherapy and Irradiation Reveals a New Strategy to Treat Pancreatic Cancer

Published:2019-11-12 Issue:1 Volume:8 Page:94-107
ISSN:2326-6066
Container-title:Cancer Immunology Research
language:en
Short-container-title:Cancer Immunol Res

Author:

Ye Jian,Mills Bradley N.,Zhao Tony,Han Booyeon J.,Murphy Joseph D.,Patel Ankit P.,Johnston Carl J.,Lord Edith M.,Belt Brian A.,Linehan David C.,Gerber Scott A.

Funder

NIH

Translational Research Grant

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Immunology

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Loss of GABARAP mediates resistance to immunogenic chemotherapy in multiple myeloma;Blood;2024-06-20

2. Synergistic action of gemcitabine and celecoxib in promoting the antitumor efficacy of anti-programmed death-1 monoclonal antibody by triggering immunogenic cell death;Translational Cancer Research;2024-06

3. Frontiers and future of immunotherapy for pancreatic cancer: from molecular mechanisms to clinical application;Frontiers in Immunology;2024-05-02

4. Prognostic utility of blood inflammation biomarkers before and after treatment on the survival of patients with locally advanced non‐small cell lung cancer undergoing stereotactic body radiotherapy;The Clinical Respiratory Journal;2024-04-29

5. Immune profiling of pancreatic cancer for radiotherapy with immunotherapy and targeted therapy: Biomarker analysis of a randomized phase 2 trial;Radiotherapy and Oncology;2024-01